The chart below shows how CGC performed 10 days before and after its earnings report, based on data from the past quarters. Typically, CGC sees a +7.39% change in stock price 10 days leading up to the earnings, and a -2.30% change 10 days following the report. On the earnings day itself, the stock moves by -6.96%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Net Revenue Analysis: Consolidated net revenue of CAD75 million in Q3, a decrease of 5% but up 8% excluding divested businesses compared to Q3 of last year.
Improved EBITDA Loss: Q3 adjusted EBITDA loss narrowed to CAD3 million, an improvement of 61% versus last year, indicating better operational efficiency.
Medical Cannabis Revenue Growth: Canada medical cannabis revenue grew by 16% year-over-year, marking another record revenue quarter and gaining market share with a growing number of insured patients.
Revenue Increase Highlights: Storz & Bickel revenue increased by 19% year-over-year to CAD22 million, driven by strong direct-to-consumer online sales and new product contributions.
SG&A Expense Reduction: SG&A expenses declined by 24% year-over-year, with year-to-date G&A costs down approximately CAD10 million versus the prior year, reflecting effective cost management strategies.
Negative
Earnings Per Share Shortfall: Canopy Growth Corporation reported an EPS of $-0.76791, missing expectations of $-0.38, indicating a significant shortfall in profitability.
Net Revenue Decline: Consolidated net revenue decreased by 5% year-over-year to CAD75 million, reflecting ongoing challenges in the market despite a slight improvement when excluding divested businesses.
Adult Use Revenue Decline: The adult use business in Canada experienced a 10% decline in net revenue year-over-year, highlighting competitive pressures and market challenges.
Free Cash Flow Concerns: Free cash flow was an outflow of CAD28 million, indicating continued cash burn despite a 17% improvement compared to the prior year, which raises concerns about liquidity.
Gross Margin Decline: The gross margin decreased to 32% from 36% a year ago, suggesting rising costs and potential inefficiencies in production.
Canopy Growth Corporation (NASDAQ:CGC) Q3 2025 Earnings Call Transcript
CGC.O
0.35%